Trulieve Cannabis (TSE:TRU – Get Free Report) was upgraded by research analysts at Atb Cap Markets from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.
Trulieve Cannabis Price Performance
About Trulieve Cannabis
TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
Read More
- Five stocks we like better than Trulieve Cannabis
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- The Most Important Warren Buffett Stock for Investors: His Own
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
